These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9859524

  • 1. [The choice of the uterine-contraction agent in managing the placental period of labor based on our data].
    Kichukova D, Milchev N, Paskaleva V, Malinova M.
    Akush Ginekol (Sofiia); 1998; 37(2):4-6. PubMed ID: 9859524
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Blood loss in the placental period in relation to the type of prophylaxis].
    Dimitrov A, Borisov S, Nalbanski B, Nikolov A, Dzherov V, Lazarova L, Gamishev G, Grigorov V.
    Akush Ginekol (Sofiia); 1996; 35(3):9-11. PubMed ID: 9045568
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor.
    Enakpene CA, Morhason-Bello IO, Enakpene EO, Arowojolu AO, Omigbodun AO.
    J Obstet Gynaecol Res; 2007 Dec; 33(6):810-7. PubMed ID: 18001447
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor.
    Chhabra S, Tickoo C.
    J Obstet Gynaecol Res; 2008 Oct; 34(5):820-3. PubMed ID: 18834340
    [Abstract] [Full Text] [Related]

  • 11. [The active management of the placental period with Remestyp].
    Dimitrov A, Nikolov A, Krŭsteva K, Lazarova L, Gŭrchev E, Karag'ozov I.
    Akush Ginekol (Sofiia); 1999 Oct; 38(4):15-7. PubMed ID: 10726344
    [Abstract] [Full Text] [Related]

  • 12. [The drug management of the placental period induced by traction on the umbilical cord].
    Rehsteiner HP.
    Ther Umsch; 1969 Aug; 26(8):450-4. PubMed ID: 5355762
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Decreased numbers of placental retention after oxytocin compared to methylergometrin].
    Borgvall B, Boström K, Hammar M.
    Lakartidningen; 1990 Feb 07; 87(6):376-7. PubMed ID: 2314178
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Administration of uterotonic drugs at the end of the expulsion stage. Comparison of the use of oxytocin and ergometrine maleate].
    Candussi G, Carlomagno G, Bouchè C, Luksa V.
    Minerva Ginecol; 1989 Nov 07; 41(11):535-40. PubMed ID: 2622579
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor.
    Lam H, Tang OS, Lee CP, Ho PC.
    Acta Obstet Gynecol Scand; 2004 Jul 07; 83(7):647-50. PubMed ID: 15225189
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.